HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Goldie Y L Lui Selected Research

taxane

1/2019Combining CDK4/6 inhibition with taxanes enhances anti-tumor efficacy by sustained impairment of pRB-E2F pathways in squamous cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Goldie Y L Lui Research Topics

Disease

8Neoplasms (Cancer)
01/2021 - 01/2013
4Neoplasm Metastasis (Metastasis)
08/2015 - 01/2013
3Carcinoma (Carcinomatosis)
01/2021 - 01/2013
3Melanoma (Melanoma, Malignant)
11/2020 - 01/2016
2Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 10/2020
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2015 - 03/2013
1Ovarian Epithelial Carcinoma
10/2020
1Lung Neoplasms (Lung Cancer)
01/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019
1Breast Neoplasms (Breast Cancer)
01/2019
1Retinoblastoma (Glioblastoma, Retinal)
01/2019
1Genomic Instability
11/2018
1Prostatic Neoplasms (Prostate Cancer)
01/2015
1Iron Overload
01/2013

Drug/Important Bio-Agent (IBA)

4IronIBA
08/2015 - 01/2013
3Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2019
3Chelating AgentsIBA
08/2015 - 01/2013
2Pharmaceutical PreparationsIBA
01/2021 - 10/2020
2Drug CombinationsIBA
10/2020 - 01/2016
2LigandsIBA
08/2015 - 01/2015
2Deferoxamine (Desferal)FDA LinkGeneric
01/2015 - 01/2013
2di- 2- pyridylketone- 4,4- dimethyl- 3- thiosemicarbazoneIBA
01/2015 - 03/2013
2Antineoplastic Agents (Antineoplastics)IBA
03/2013 - 01/2013
1MK 2206IBA
01/2021
1ipatasertibIBA
01/2021
1Small Interfering RNA (siRNA)IBA
01/2021
1AlpelisibIBA
01/2021
1AntimetabolitesIBA
10/2020
1Vinca AlkaloidsIBA
10/2020
1rucaparibIBA
10/2020
1Poly(ADP-ribose) Polymerase InhibitorsIBA
10/2020
1Dasatinib (BMS 354825)FDA Link
10/2020
1navitoclaxIBA
10/2020
1AnthracyclinesIBA
10/2020
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2020
1Taxoids (Taxanes)IBA
01/2019
1palbociclibIBA
01/2019
1taxaneIBA
01/2019
1GTP Phosphohydrolases (GTPases)IBA
01/2019
1Retinoblastoma ProteinIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
11/2018
1Messenger RNA (mRNA)IBA
11/2018
1Proteasome InhibitorsIBA
01/2016
1Bortezomib (Velcade)FDA Link
01/2016
1Temozolomide (Temodar)FDA LinkGeneric
01/2016
1Alkylating AgentsIBA
01/2016
1Mitogen-Activated Protein KinasesIBA
01/2016
1ThiosemicarbazonesIBA
08/2015
1di-2-pyridylketone 4- cyclohexyl- 4- methyl- 3- thiosemicarbazoneIBA
01/2015
1MetalsIBA
01/2015
1InterleukinsIBA
01/2015
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2015
1DeferasiroxFDA Link
01/2013
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2013
1Caspase 3 (Caspase-3)IBA
01/2013

Therapy/Procedure

6Therapeutics
01/2021 - 08/2015
1Drug Therapy (Chemotherapy)
01/2019